Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline for Erlotinib-induced Diarrhea
NCT02080078Phase 1Terminated
- Sponsor
- American Health Staffing Group
- Start
- Sep 2014
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of theophylline in diarrhea (2 arms), sponsored by American Health Staffing Group. Primary endpoint: The lowest effective dose of theophylline that will prevent or maximally ameliorate erlotinib's diarrhea at 28 days. Started Sep 2014; status: terminated.
02
Drugs
theophylline
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02080078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02080078.